Identification of neoantigen-specific lymphocytes for its direct use in cancer immunotherapy: another emerging application of liquid biopsy in Cancer treatment.

  A recent research letter in Nature Medicine by Alena Gros et al has opened a novel window for treatment of cancer tumors using personalized neoantigen-specific lymphocytes. In their study they have successfully identified patient-specific repertoire of tumor reactive CD8+ lymphocytes from peripheral blood. (a),
</p>
						</div><!-- .entry-summary -->
									
		
		<footer class=